tradingkey.logo

Abbott falls after judge rules retrial in infant formula case

ReutersMar 14, 2025 3:16 PM

Shares of Abbott Laboratories ABT.N fall 2.85% to $126.19

A judge in the Whitfield infant formula case granted a retrial to the plaintiffs following the October 31, 2024 verdict that handed a unanimous win in favor of Abbott and Reckitt's RKT.L unit Mead Johnson

The ruling found the companies were not liable for failing to warn of the risks around necrotizing enterocolitis (NEC) in their infant formula products

Today's ruling marks a setback following what seemed like a step in the right direction - J.P.Morgan

ABT shares up ~8% in the last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI